AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.25926
Vol. 88, No. 6, 1611-1617, December 2008

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cusick, S. E
Right arrow Articles by Cogswell, M. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cusick, S. E
Right arrow Articles by Cogswell, M. E
Agricola
Right arrow Articles by Cusick, S. E
Right arrow Articles by Cogswell, M. E
© 2008 American Society for Clinical Nutrition

Nutritional epidemiology and public health

Unexplained decline in the prevalence of anemia among US children and women between 1988–1994 and 1999–20021,2,3

Sarah E Cusick, Zuguo Mei, David S Freedman, Anne C Looker, Cynthia L Ogden, Elaine Gunter and Mary E Cogswell

1 From the US Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition, Physical Activity, and Obesity (SEC, ZM, DSF, and MEC); National Center for Health Statistics (ACL and CLO) and National Center for Environmental Health (EG), Atlanta, GA

See corresponding editorial on page 1457.

2 The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

3 Reprints not available. Address correspondence to SE Cusick, 4770 Buford Highway, MS K-25, Atlanta, GA 30341. E-mail: scusick{at}cdc.gov.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: The current anemia burden among US preschool children and women of childbearing age has not been documented.

Objective: We used data from National Health and Nutrition Examination Surveys 1988–1994 and 1999–2002 to examine recent anemia changes.

Design: We calculated the prevalence of anemia (hemoglobin < 11.0 g/dL at <24 mo, <11.1 g/dL at 24–59 mo, and <12.0 g/dL for women), iron deficiency anemia (anemia plus abnormal value ≥2: serum ferritin, transferrin saturation, and erythrocyte protoporphyrin), and high blood lead (≥10 µg/dL) with anemia among children 12–59 mo and women 20–49 y in both surveys. Among women, we also calculated the prevalence of folate deficiency (erythrocyte folate < 317.2 nmol/L) with anemia and high C-reactive protein (>10 mg/L) with anemia. Multiple logistic regression was used to compare anemia prevalence between surveys, with control for race and age.

Results: Anemia declined significantly in children (from 8.0% to 3.6%; OR: 0.4; 95% CI: 0.3, 0.7) and women (10.8% to 6.9%; OR: 0.6; CI: 0.4, 0.7), but the prevalence of iron deficiency anemia did not change significantly in children (1.5% compared with 1.2%; OR: 0.7; 95% CI: 0.4, 1.5) or women (4.9% compared with 4.1%; OR: 0.8; 95% CI: 0.6, 1.1). Folate deficiency with anemia declined significantly in women (from 4.1% to 0.5%; OR: 0.1; 95% CI: 0.1, 0.2), but logistic regression models and standardization indicated that none of the known possible anemia causes could account for the decline in total anemia in children or women.

Conclusions: The prevalence of anemia declined significantly among US women and children between 1988–1994 and 1999–2002, but this decline was not associated with changes in iron or folate deficiency, inflammation, or high blood lead.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Anemia is a condition in which the number of red blood cells or their oxygen-carrying capacity is not adequate to meet normal physiologic demands (1). Iron deficiency is believed to be the most common cause of anemia worldwide (2), but deficiencies of other vitamins, inflammation, infections, and inherited hemoglobin disorders can also cause anemia (3-5).

Depending on the cause of anemia, the consequences of the condition are potentially serious and long-lasting. The consequences of iron deficiency anemia—including impaired cognitive and motor development (6-9) and increased susceptibility to lead poisoning (10, 11) in young children and impaired aerobic capacity and reduced work productivity (12, 13) in adults—have been widely reported, but anemia resulting from other nutritional deficiencies or inflammation can also reflect harmful health conditions. Among other possible causes of nutritional anemia, folate deficiency is associated with an increased risk of neural tube defects and may also be associated with adverse pregnancy outcomes, cardiovascular disease, depression, and dementia, whereas vitamin B-12 deficiency may be associated with an increased risk of heart disease and neuropathy (14-18). Anemia resulting from vitamin A deficiency may be linked with impaired immunity, growth, and vision (19). Anemia can also indicate inflammation caused by a variety of conditions, including infection, or it may occur in chronic illnesses such as chronic renal disease or endocrine disorders that can result in decreased erythropoiesis (4, 20).

Earlier data indicated that the prevalence of anemia declined in the 1970s and 1980s in US preschool children, but not among women of childbearing age (21, 22). The current burden of anemia in these 2 high-risk groups in the United States is unclear. In the present study, we used data from 2 recent National Health and Nutrition Examination Surveys (NHANES 1988–1994 and 1999–2002) to examine recent changes in total anemia prevalence. We also investigated between-survey changes in the prevalence of several types of anemia, including anemia associated with iron deficiency, folate deficiency, vitamin B-12 deficiency, vitamin A deficiency, high blood lead, and inflammation to assess whether these factors played a role in any observed changes in total anemia. Identification of a likely cause for changes in anemia could highlight existing public health interventions that have been successful or could identify new interventions that might be considered.


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The NHANES are multistage, nationally representative surveys of the US civilian, noninstitutionalized population (23, 24). Each participant is interviewed at home, and most participants also undergo a physical evaluation in a mobile examination center. We began with all children aged 12–59 mo and women aged 20–49 y in NHANES 1988–1994 and 1999–2002 who had a physical exam (1988–1994: n = 4812 children, n = 5104 women; 1999–2002: n = 1978 children, n = 2782 women). We excluded pregnant women and women whose pregnancy status could not be ascertained (1988–1994: n = 338; 1999–2002: n = 701), any woman with a missing value for red blood cell folate or C-reactive protein (CRP), and any participant with a missing value for hemoglobin, serum ferritin, erythrocyte protoporphyrin, transferrin saturation, or blood lead. We were unable to include red blood cell folate or CRP in the children's analyses because they were assessed only in children ≥4 y during 1988–1994 and in children ≥3 y during 1999–2002. Total exclusions for missing laboratory data were as follows: n = 2026 children and n = 374 women for 1988–1994 and n = 776 children and n = 112 women for 1999–2002. After the exclusions, the final sample size for each survey was as follows: n = 2786 children and n = 4392 women for 1988–1994 and n = 1202 children and n = 1969 women for 1999–2002.

Phlebotomy refusal was the primary reason for missing laboratory data among children in both surveys (AC Looker, personal communication) (25). We compared the race/ethnicity distribution and income status of children excluded for having missing laboratory values with those of included children and found that whereas the race/ethnicity distribution was not significantly different in either survey, excluded children in both surveys were less likely to be of low income (family income ≤130% of the US poverty threshold) than were included children (1988–1994: 31% compared with 40%, chi-square test P < 0.01; 1999–2002: 34% compared with 44%, chi-square test P = 0.01).

In contrast, women excluded in 1999–2002 for having missing laboratory data were more likely to be of low income than were their included counterparts (39% compared with 25%, chi-square test P = 0.02). Excluded women were also more likely to be of non-Hispanic black race/ethnicity than were their included counterparts in both surveys (1988–1994: 21% compared with 12%, chi-square test P = 0.01; 1999–2002: 23% compared with 12%, chi-square test P < 0.01).

Finally, because serum vitamin B-12 and retinol were not measured for the entirety of both surveys, we constructed a subsample of women in each survey who also had data for serum vitamin B-12 (1991–1994: n = 2506; 1999–2002: n = 1968) and serum retinol (1988–1994: n = 4378; 1999–2000: n = 903). This subanalysis was not possible for children because both indicators were assessed only in children ≥4 y during 1988–1994 and in children ≥3 y during 1999–2002.

Laboratory methods
In both surveys, blood was collected from study participants ≥1 y by venipuncture. Hemoglobin was measured as part of a complete blood count done with a Coulter S-plus Jr in 1988–1994 and with a Coulter MAXM in 1999–2002 (both from Coulter Electronics, Hialeah, FL). The laboratory methods for other indicators were described in detail elsewhere (26-28). Briefly, serum ferritin was measured by using the Bio-Rad QuantImune Ferritin immunoradiometric assay (Bio-Rad Laboratories, Hercules, CA), whereas transferrin saturation was calculated as serum iron divided by total-iron-binding capacity, as measured by a Centers for Disease Control and Prevention modification of the automated Technicon AAII-25 ferrozine colorimetric method (Alpkem TFA analyzer; Alpkem, Clackamas, OR). Free erythrocyte protoporphyrin was measured in whole blood by fluorescence extraction by using a modification of the Sassa method. Red blood cell folate was measured with the QuantaPhase-I Folate Radioassay Kit (Bio-Rad Laboratories) from 1988 to 1991 and with the QuantaPhase-II kit from 1991 to 1994 and from 1999 to 2001. The QuantaPhase-II kit reflected recalibration of the assay for which appropriate adjustments were made to the 1988–1991 values to make them comparable with the 1991–2001 values before public release. The QuantaPhase II assay also measured serum vitamin B-12. During both surveys, serum CRP was measured by latex-enhanced nephelometry (lower limit of detection: 0.2 mg/L). Blood lead was measured by atomic absorption spectroscopy, and serum retinol was measured by HPLC.

Cutoffs and definitions
Hemoglobin cutoffs used to define anemia and cutoffs used for defining abnormal values for indicators of iron status, blood lead, red blood cell folate, CRP, retinol, and vitamin B-12 are presented in Table 1Go. We defined iron deficiency as having an abnormal value for ≥2 of the 3 following indicators: serum ferritin, transferrin saturation, and erythrocyte protoporphyrin (29). We defined iron deficiency anemia as iron deficiency plus anemia.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Cutoffs for defining abnormal values of biochemical indicators used in the study1

 
Statistical analysis
All analyses were conducted with SAS 8.2 with SUDAAN (SAS Institute Inc, Cary, NC) and used sample weights to account for differential probabilities of selection and complex sampling design. For children and women in each survey, we first calculated the prevalence of total anemia. Among children, we then calculated the prevalence of iron deficiency anemia, the prevalence of high blood lead with anemia, and the prevalence of the coexistence of iron deficiency, high blood lead, and anemia. Among women, we calculated the prevalence of iron deficiency anemia, folate deficiency with anemia, high CRP with anemia, high blood lead with anemia, and the coexistence of ≥2 of these conditions with anemia. We also calculated the prevalence of vitamin B-12 deficiency with anemia and the prevalence of vitamin A with anemia among women in the sub-sample.

We then used multiple logistic regression to compare overall anemia prevalence and type-specific anemia prevalence between the surveys for children and women, controlling for race/ethnicity, sex (in the children's models), and age. We further adjusted the children's overall anemia model for iron deficiency and high blood lead and the women's overall anemia model for iron deficiency, high blood lead, folate deficiency, and high CRP to assess the role of these potential causes of anemia in any observed change in anemia prevalence.

Because preliminary analyses and recently published data (36) indicated that the prevalence of folate deficiency declined significantly among women of childbearing age between the surveys, we used direct standardization to examine the possible effect this decline had on the prevalence of anemia between the surveys (37).

Finally, to investigate the possibility of a systematic difference in hemoglobin measurement between the surveys, we constructed mean-difference plots for hemoglobin among women by subtracting hemoglobin values at each percentile in 1988–1994 from hemoglobin values at the corresponding percentile in 1999–2002 and plotting this difference on the y axis, with hemoglobin in the first survey on the x axis (38).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The racial distribution and income status for children and women were similar between the 2 surveys, although women in 1999–2002 tended to have a higher prevalence of family income ≤130% of the Federal Poverty Threshold than did women in 1988–1994 (P = 0.05; Table 2Go).


View this table:
[in this window]
[in a new window]

 
TABLE 2. Sample demographics, by survey1

 
Among children, the prevalence of all-cause anemia decreased significantly between the 2 surveys, falling from 8.0% to 3.6%, with a corresponding adjusted odds ratio (OR) of 0.4 (95% CI: 0.3, 0.7; Table 3Go). However, the prevalence of iron deficiency anemia was low (< 2%) and did not change significantly between the surveys (OR: 0.7; 95% CI: 0.4, 1.5). The prevalence of high blood lead with anemia declined significantly, but was <1% in either survey. Coexisting iron deficiency, high blood lead and anemia was rare in either survey.


View this table:
[in this window]
[in a new window]

 
TABLE 3. Prevalence and change in total anemia and type-specific anemia in 1988-1994 and 1999–20021

 
The prevalence of all-cause anemia also declined significantly among women, falling 4 percentage points from 10.8% to 6.9% (OR: 0.6; 95% CI: 0.4, 0.7; Table 3Go). Iron deficiency anemia was the predominant known type of anemia among women in both surveys, but its prevalence did not change significantly (OR: 0.8; 95% CI: 0.6, 1.1). The prevalence of folate deficiency with anemia, however, declined significantly by almost 4 percentage points (from 4.1% to 0.5%; OR: 0.1; 95% CI: 0.1, 0.2), and the proportion of women with ≥2 types of anemia declined by more than a percentage point. Further analysis showed that >70% of the women in 1988–1994 who had 2 types of anemia had concurrent iron and folate deficiency (data not shown). High blood lead, inflammation, vitamin A deficiency, and vitamin B-12 deficiency concurrent with anemia were rare among women in both surveys (<1%; subsample data not shown).

Type-specific anemia patterns remained when we stratified by race/ethnicity category (Table 4Go). The prevalence of anemia declined significantly in each race/ethnicity group, but the prevalence of iron deficiency anemia did not change significantly in any group and remained high among both black (12%) and Mexican American (8%) women. The prevalence of folate deficiency with anemia declined significantly in each race/ethnicity group.


View this table:
[in this window]
[in a new window]

 
TABLE 4. Prevalence and change in total anemia and type-specific anemia for women aged 20-49 y by race/ethnicity in 1988-1994 and 1999-20021

 
Multiple logistic regression showed, however, that none of the potential anemia causes fully explained the decline in anemia among children or women. When we modeled anemia among children as a function of survey (1999–2002 compared with 1988–1994), race/ethnicity, age, and sex, the OR for the survey was 0.42 (Table 3Go; second row). The OR remained 0.42 when iron deficiency and high blood lead were added to the model. Similarly, among women, the OR for the survey was 0.56 in the model that adjusted only for race/ethnicity and age (Table 3Go; second row) and was 0.46 after the model was adjusted for iron deficiency, folate deficiency, high blood lead, and high CRP.

Preliminary analyses showed that the prevalence of folate deficiency among women in our sample was 36% in 1988–1994 and 4.5% in 1999–2002. To assess further whether this decline played a role in the decline in anemia that we observed, we used direct standardization and found that if the prevalence of folate deficiency had remained 36% in both surveys, the prevalence of anemia would have declined from 11% to 8%, similar to the decline in unadjusted prevalences of 11% to 7% (Table 3Go). Furthermore, additional analyses showed that among nonfolate-deficient women in each survey, the prevalence of anemia also declined from 11% to 7% between the surveys.

To assess the possibility of a systematic error in hemoglobin measurement, we constructed mean-difference plots for hemoglobin among women by subtracting hemoglobin values at each hemoglobin percentile in 1988–1994 from the hemoglobin values at the corresponding percentile in 1999–2002 (Figure 1Go). We then plotted this difference (in g/dL) along the y axis with hemoglobin in 1988–1994 along the x axis. For example, among black women, the 10th, 50th, and 90th percentiles of hemoglobin were 11.1, 12.6, and 13.8 g/dL, respectively, in the first survey and were 11.1, 12.7, and 14.1 g/dL, respectively, in the second survey. The differences in these percentile values (1999–2002 minus 1988–1994) were 0.0, 0.1, and 0.3 g/dL, which fall along the line in the middle panel of the Figure 1Go. We found that the magnitude of change in hemoglobin values differed by race/ethnicity group, with a greater increase in hemoglobin observed among white (median difference: +0.34) and Mexican American (+0.37) women than among black women (+0.13).


Figure 1
View larger version (13K):
[in this window]
[in a new window]

 
FIGURE 1.. Plot of differences in hemoglobin values at various percentiles for women by race/ethnicity group. Within each race/ethnicity group, the hemoglobin values at each percentile for 1988–1994 were subtracted from hemoglobin values at the corresponding percentile in 1999–2002. The differences in each percentile (from the 1st to the 99th) were smoothed by using lowess, a nonparametric technique based on estimates of the values at each point from a weighted regression analysis of neighboring points (38).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The prevalence of anemia declined significantly between 1988–1994 and 1999–2002 among US preschool-aged children and women of childbearing age, but the cause of this decline was largely unexplained. The prevalence of iron deficiency anemia remained low and unchanged between the 2 surveys in both groups, and although the prevalence of folate deficiency with anemia did decline significantly among women, changes in the prevalence of folate deficiency accounted for little of the overall decline in anemia. Inflammation, high blood lead, vitamin B-12 deficiency, and vitamin A deficiency concurrent with anemia were not common in either survey.

The majority of anemia among children in both surveys was not associated with iron deficiency or high blood lead. The observed low prevalence of iron deficiency anemia among US preschool children was likely the result of concerted efforts to prevent iron deficiency anemia in this vulnerable age group, including iron fortification of infant formulas and establishment of The Special Supplemental Nutrition Program for Women, Infants, and Children in the early 1970s (21, 39-41). Blood lead concentrations have also declined significantly since the 1970s, largely because of the removal of lead from gasoline and soldered cans (42, 43).

The cause of the decline in the prevalence of anemia among children between the surveys is thus unclear, and, unfortunately, the lack of data on folate, vitamin B-12, serum retinol, and CRP among children surveyed in this age group limited our investigation of potential causes. Others have reported the importance of common infections, including upper respiratory tract infection, otitis media, and gastroenteritis as causes of anemia in preschool-aged children (20), but whether the frequency of these infections decreased sufficiently between the surveys to contribute to the decline in all-cause anemia among children is not known.

Iron deficiency anemia was the predominant type of anemia among women in both surveys and was most prevalent in black and Mexican American women. The cause of the persistently high prevalence among women in these race/ethnicity groups merits further attention, but may be due to lower socioeconomic status, lower attained education, or higher parity, all of which are associated with iron deficiency in women of childbearing age (30). Nevertheless, the prevalence of iron deficiency anemia did not change significantly between the 2 surveys among all women or in any race/ethnicity group and thus seems unlikely to explain the significant decline in the prevalence of all-cause anemia.

We did observe a significant decline in the prevalence of concurrent folate deficiency and anemia among women, but this decline appeared to be the result of concomitant, but unrelated, declines in both folate deficiency and anemia. Several authors have reported multiple beneficial effects of the 1998 folic acid fortification of all US enriched cereal-grain products, including a reduced prevalence of neural tube disorders (44, 45) and lower concentrations of homocysteine (46, 47). No study has evaluated the effect of folic acid fortification on anemia. The timing of NHANES 1988–1994 (before fortification) and 1999–2002 (after fortification) permitted us to evaluate such an association, but regression and standardization results failed to prove a relation.

Another possible cause of the observed decline in anemia was a systematic difference in hemoglobin measurement between the surveys, introduced by the use of 2 different models of Coulter counter. A direct investigation, in which both instruments are used to measure hemoglobin on the same sera samples, was not possible because the instruments used in 1988–1994 were no longer available. We instead used an indirect approach to assess this possibility by subtracting hemoglobin values at various percentiles of the first survey from hemoglobin values at the corresponding percentiles of the second survey and then plotting this difference on the y axis with hemoglobin in the first survey on the x axis. These results suggest that a systematic difference in hemoglobin concentrations between the 2 surveys did not play a major role in the observed decline in the prevalence of anemia, because the patterns and magnitude of hemoglobin differences were different for each race/ethnicity group.

Important health trends over the past 3 decades, specifically the decline in cigarette smoking (48) and the increase in overweight and obesity (49, 50), have the potential to affect anemia rates, but likely in a direction opposite of what we observed. Among women in NHANES II, smokers had a significantly higher mean hemoglobin concentration than did nonsmokers and a lower prevalence of anemia (51), but the declining smoking rates between 1988 and 2002 (48) would be more consistent with a lower hemoglobin concentration and a higher prevalence of anemia. Similarly, overweight may be associated with an increased risk of iron deficiency (52), whereas a high prepregnancy body mass has been found to be associated with a greater risk of postpartum anemia (53), but both would be consistent with an increase, rather than with a decline, in anemia.

A limitation of our study was the possibility of selection bias introduced by the large number of children with missing laboratory data, due primarily to phlebotomy refusal. Although the race/ethnicity of children with missing laboratory data was not significantly different from included children, included children were significantly more likely to be of low income, which potentially inflated the anemia estimates. However, the relative amount of bias by income in the 2 surveys appears similar (1988–1994: 31% low income in the excluded sample compared with 40% in the included sample; 1999–2002: 34% compared with 44%). This finding suggests that the difference in prevalence between the surveys observed in our study was unlikely to be seriously affected.

Whereas a much smaller proportion of women than children were excluded because of missing laboratory values, excluded women in both surveys were more like to be of non-Hispanic black race/ethnicity than were included women, perhaps leading to an underestimation of total anemia and/or iron deficiency anemia. Again, however, the relative amount of bias by race in the 2 surveys appeared to be similar (1988–1994: 21% low income in the excluded sample compared with 12% in the included sample; 1999–2002: 23% compared with 12%). Excluded women also tended to have a higher prevalence of poverty in 1999–2002. Adjustment for poverty in multivariate models for anemia, however, did not change the OR estimates, which made it unlikely that this finding significantly affected our overall results.

Our restricted ability to assess inflammation was an additional limitation. CRP tends to peak and diminish rapidly and thus may not reflect more chronic inflammatory conditions (54). We were also unable to account for other possible causes of anemia, including hemoglobinopathies, cancer, and aplastic anemia resulting from reduced red blood cell production; however, these conditions were probably not common in the children and young adult women.

In summary, we observed a significant decline in the prevalence of all-cause anemia between 1988–1994 and 1999–2002. Whereas the explanation for the decline remains unclear, the reduced anemia burden among US children and women is notable in that anemia itself is associated with multiple adverse health outcomes, including mild-to-moderate mental retardation in children (55) and low infant birth weight and increased risk of preterm birth in pregnant women (56). Although iron deficiency anemia was not prevalent among preschool-aged children in either survey, it remains prevalent among women of childbearing age, particularly among black and Mexican American women. Further investigation of the lack of association between folate deficiency and anemia may warrant further investigation.


    ACKNOWLEDGMENTS
 
We thank Ann Do for her thoughtful review of the manuscript.

The authors' responsibilities were as follows—MEC and ACL: conducted the preliminary analyses; SEC, MEC, DSF, ZM, ACL, and CLO: developed the analytic plan; EG: reviewed the laboratory components and conducted relevant quality-control analysis; SEC: wrote the manuscript; and SEC and DSF: conducted the analyses. All authors reviewed the manuscript. None of the authors had a conflict of interest.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Tortora GJ, Grabowski SR. Principles of anatomy and physiology. New York, NY: Wiley & Sons, Inc, 2000.
  2. Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull 2003;24(suppl):S99–103.[Medline]
  3. Totin D, Ndugwa C, Mmiro F, Perry RT, Jackson JB, Semba RD. Iron deficiency anemia is highly prevalent among human immunodeficiency virus-infected and uninfected infants in Uganda. J Nutr 2002;132:423–9.[Abstract/Free Full Text]
  4. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80(7):1639–47.[Abstract/Free Full Text]
  5. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985;38:302–16.[Medline]
  6. Lozoff B, de Andraca I, Castillo M, Smith JB, Walter T, Pino P. Behavioral and developmental effects of preventing iron deficiency anemia in healthy full-term infants. Pediatrics 2003;112:846–54.[Abstract/Free Full Text]
  7. Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 1991;325:687–94.[Abstract]
  8. Idjradinata P, Pollitt E. Reversal of developmental delays in iron-deficient anaemic infants treated with iron. Lancet 1993;34:1–4.[Medline]
  9. Grantham-McGregor S, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 2001;131:649S–68S.[Abstract/Free Full Text]
  10. Wright RO, Tsaih SW, Schwartz J, Wright RJ, Hu H. Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic. J Pediatr 2003;142:9–14.[CrossRef][Medline]
  11. Kwong WT, Friello P, Semba RD. Interactions between iron deficiency and lead poisoning: epidemiology and pathogenesis. Sci Total Environ 2004;330:21–37.[CrossRef][Medline]
  12. Scholz BD, Gross R, Schultink W, Sastroamidjojo S. Anaemia is associated with reduced productivity of women workers even in less-physically strenuous tasks. Br J Nutr 1997;77:47–57.[Medline]
  13. Haas JD, Brownlie IVT. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001;131:676S–90S.[Abstract/Free Full Text]
  14. Michalis LK, Pappas K, Tweddel A, et al. Relatively low red cell folate levels and acute coronary syndromes. Coron Artery Dis 2001;12:665–8.[CrossRef][Medline]
  15. Mischoulon D, Raab MF. The role of folate in depression and dementia. J Clin Psychiatry 2007;68(suppl):28–33.
  16. Pitkin RM. Folate and neural tube defects. Am J Clin Nutr 2007;85:285S–8S.[Abstract/Free Full Text]
  17. Sadeghian S, Fallahi F, Salarifar M, et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord 2006;6:38.[CrossRef][Medline]
  18. Saperstein DS, Barohn RJ. Peripheral neuropathy due to cobalamin deficiency. Curr Treat Options Neurol 2002;4:197–201.[CrossRef][Medline]
  19. World Health Organization. Vitamin A deficiency and its consequences: a field guide to detection and control. 3rd ed. Geneva, Switzerland: WHO, 1995.
  20. Dallman PR, Yip R. Changing characteristics of childhood anemia. J Pediatr 1989;114:161–4.[CrossRef][Medline]
  21. Yip R, Binkin NJ, Fleshwood L, Trowbridge FL. Declining prevalence of anemia among low-income children in the United States. JAMA 1987;258:1619–23.[Abstract/Free Full Text]
  22. Expert Scientific Working Group. Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr 1985;42:1318–30.[Abstract/Free Full Text]
  23. Centers for Disease Control and Prevention. Analytic and reporting guidelines: the Third National Health and Examination Survey, NHANES III (1988-94). October 1996. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf (cited 28 June 2007).
  24. Centers for Disease Control and Prevention. Analytic guidelines. June 2004. Available from: http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/analytical_guidelines.htm (cited 28 June 2007).
  25. Mohadjer L, Bell B, Waksberg J. National Health and Nutrition Examination Survey III. Accounting for item nonresponse bias. Rockville, MD: Westat Inc, Nov 4 1994:10.
  26. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
  27. National Center for Health Statistics. National Health and Nutrition Examination Survey. Lab methods 1999-2000. Available from: http://www.cdc.gov/nchs/about/major/nhanes/lab_methods99_00.htm (cited 9 January 2007).
  28. National Center for Health Statistics. National Health and Nutrition Examination Survey. Lab methods 2001-2002. Available from: http://www.cdc.gov/nchs/about/major/nhanes/lab_methods01_02.htm (cited 9 January 2007).
  29. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998;47:1–29.[Medline]
  30. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997;277:973–6.[Abstract/Free Full Text]
  31. Centers for Disease Control and Prevention. Blood lead levels—United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005;54:513–6.[Medline]
  32. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. A report of the standing committee on the scientific evaluation of dietary references intakes and its panel on folate, other B vitamins and choline and subcommittee on upper reference levels of nutrients. Washington, DC: National Academy Press, 1998.
  33. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001;138:486–92.[CrossRef][Medline]
  34. de Pee S, Dary O. Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein. J Nutr 2002;132:2895S–901S.[Abstract/Free Full Text]
  35. Miller JW, Garrod MG, Rockwood AL, et al. Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem 2006;52:278–85.[Abstract/Free Full Text]
  36. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 2007;86:718–27.[Abstract/Free Full Text]
  37. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Hyattsville, MD: National Center for Health Statistics, January 2001. (Healthy People Statistical Notes, no. 20.)
  38. Cleveland WS. The elements of graphing data. Monterey, CA: Wadsworth Advanced Books and Software, 1985.
  39. Yip R, Walsh KM, Goldfarb MG, Binkin NJ. Declining prevalence of anemia in childhood in a middle-class setting: a pediatric success story? Pediatrics 1987;80:330–4.[Abstract/Free Full Text]
  40. Sherry B, Mei Z, Yip R. Continuation of the decline in prevalence of anemia in low- income infants and children in five states. Pediatrics 2001;107:677–82.[Abstract/Free Full Text]
  41. American Academy of Pediatrics, Committee on Nutrition. Iron fortification of infant formulas. Pediatrics 1999;104:119–23.[Abstract/Free Full Text]
  42. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994;272:284–91.[Abstract/Free Full Text]
  43. Meyer PA, Pivetz T, Dignam TA, Homa DM, Schoonover J, Brody D. Surveillance for elevated blood lead levels among children–United States, 1997-2001. MMWR Morb Mortal Wkly Rep Surveill Summ 2003;52(10):1–21.
  44. Centers for Disease Control. Spina bifida and anencephaly before and after folic acid mandate. United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 2004;53:362–5.[Medline]
  45. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981–6.[Abstract/Free Full Text]
  46. Ganji VV, Kafai MR. Trends in serum folate, rbc folate, and circulating total homocysteine concentrations in the United States: analysis of data from National Health and Nutrition Examinations Surveys, 1988-1994, 1999-2000, and 2001-2002. J Nutr 2006;136:153–8.[Abstract/Free Full Text]
  47. Ganji V, Kafai MR. Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Am J Clin Nutr 2006;84:989–94.[Abstract/Free Full Text]
  48. US Centers for Disease Control and Prevention. Smoking and tobacco use. Available from: http://www.cdc.gov/tobacco/data_statistics/tables/adult/table_2.htm (cited 22 May 2008).
  49. Polhamus B, Dalenius K, Borland E, Smith B, Grummer-Strawn L. Pediatric Nutrition Surveillance 2006 Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
  50. Ogden CL, Fryar CD, Carroll MD, Flegal KM. Mean body weight, height, and body mass index, United States 1960-2002. Adv Data 2004;27:1–17.[Medline]
  51. Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA 1990;264:1556–9.[Abstract/Free Full Text]
  52. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004;114:104–8.[Abstract/Free Full Text]
  53. Bodnar LM, Siega-Riz AM, Cogswell ME. High prepregnancy BMI increases the risk of postpartum anemia. Obes Res 2004;12:941–8.[CrossRef][Medline]
  54. Gabay C, Kushner I. Acute phase proteins and other systematic responses to inflammation. N Engl J Med 1999;340:448–54.[Free Full Text]
  55. Hurtado EK, Claussen AH, Scott KG. Early childhood anemia and mild to moderate mental retardation. Am J Clin Nutr 1999;69:115–9.[Abstract/Free Full Text]
  56. Rasmussen KM. Is there a causal relationship between iron deficiency, iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality? J Nutr 2001;131:590S–603S.[Abstract/Free Full Text]
Received for publication January 28, 2008. Accepted for publication July 15, 2008.


Related articles in AJCN:

Anemia in at-risk populations—what should be our focus?
Donald H Mahoney, Jr
AJCN 2008 88: 1457-1458. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
H. A Eicher-Miller, A. C Mason, C. M Weaver, G. P McCabe, and C. J Boushey
Food insecurity is associated with iron deficiency anemia in US adolescents
Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1358 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. H Mahoney Jr
Anemia in at-risk populations--what should be our focus?
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1457 - 1458.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cusick, S. E
Right arrow Articles by Cogswell, M. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cusick, S. E
Right arrow Articles by Cogswell, M. E
Agricola
Right arrow Articles by Cusick, S. E
Right arrow Articles by Cogswell, M. E


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS